Essential Thrombocythaemia
6 clinical trials · Condition
◉ Watch Essential Thrombocythaemia
| Record | Firm | Date |
|---|---|---|
| Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia (NCT01230775) | AOP Orphan Pharmaceuticals AG | 2010-12-01 |
| The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) (NCT00413634) | Shire | 2006-11-13 |
| Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia (NCT01065038) | AOP Orphan Pharmaceuticals AG | 2002-09-01 |
Track Essential Thrombocythaemia automatically
Every clearance here is in the API, with alerts when new ones post.